Background
Perinatally-acquired HIV infection commonly causes stunting in children; how this affects bone and muscle development is unclear. We investigated differences in bone and muscle mass and muscle function between children with HIV (CWH) and uninfected children.
Setting
Cross-sectional study of CWH (6–16 years) receiving antiretroviral therapy (ART) for >6 months and similar aged children testing HIV-negative at primary health clinics in Zimbabwe.
Methods
From Dual-energy X-ray Absorptiometry (DXA) we calculated total-body less-head (TBLH) Bone Mineral Content (BMC) for lean mass adjusted-for-height (TBLH-BMC
LBM
) Z-scores, and lumbar spine (LS) Bone Mineral Apparent Density (BMAD) Z-scores.
Results
The 97 CWH were older (mean age 12.7
vs.
10.0 years) and taller (mean height 142 cm
vs.
134 cm) than 77 uninfected. However, stunting (height-for-age Z-score ≤ −2) was more prevalent in CWH (35%
vs.
5%,
p
< 0.001). Among CWH, 15% had low LS-BMAD (Z-score ≤ −2) and 13% low TBLH-BMC
LBM
,
vs.
1% and 3% respectively in those uninfected (both
p
≤ 0.02). After age, sex, height and puberty adjustment, LS-BMAD was 0.33 SDs (95%CI -0.01, 0.67;
p
= 0.06) lower in CWH, with no differences by HIV status in TBLH-BMC
LBM
, lean mass (0.11 [−0.03, 0.24],
p
= 0.11) or grip strength (0.05 [−0.16, 0.27],
p
= 0.62). However, age at ART initiation was correlated with both LS-BMAD Z-score (r = −0.33,
p
= 0.001) and TBLH-BMC
LBM
Z-score (r = −0.23,
p
= 0.027); for each year ART initiation was delayed a 0.13 SD reduction in LS-BMAD was seen.
Conclusion
Size-adjusted low bone density is common in CWH. Delay in initiating ART adversely affects bone density. Findings support immediate ART initiation at HIV diagnosis.